by
John R. Fischer, Senior Reporter | January 19, 2023
Slowdowns are already being seen at China’s biggest ports, and manufacturers are struggling to complete orders, according to CNBC. Ocean crossings are also decreasing, though it is not yet known if this is linked to COVID.
China is also running on low on certain products, including fever medications, such as ibuprofen and acetaminophen. It could curb exportation of these and other goods to care for their own population. U.S. officials say they do not anticipate shortages with those medications, saying that Johnson & Johnson makes Tylenol and Motrin, and does not get the active ingredients from China.
Ad Statistics
Times Displayed: 40894
Times Visited: 1138 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
Having experienced these issues in 2020, healthcare officials say they hope that the U.S. is in a better position to deal with any disruptions than it was then.
“It feels like there’s room to absorb some potential impact of this. Now, down to what degree is kind of harder to put your thumb on, due to the potentially very large-scale level of COVID cases," said Kyle MacKinnon, senior director of operational excellence at Premier, which helps healthcare providers manage their supply chains.
Back to HCB News
